APACHE II Score in ICU: Purpose and Clinical Application

Overview of APACHE II Score

• The APACHE II score is the most effective tool for predicting mortality in ICU patients, with superior discriminative power (pooled AUC of 0.81) compared to other scoring systems, and is used primarily to assess disease severity and predict mortality risk in critically ill patients 1, 2
• APACHE II was introduced in 1985 to reflect both premorbid factors (patient age and chronic medical conditions) and acute changes in 12 physiologic parameters 1
• APACHE II has demonstrated the highest accuracy for predicting severe acute conditions compared to other scoring systems 3

Components and Calculation

• APACHE II incorporates 12 physiologic variables, age, type of hospital admission, and chronic health evaluation 4, 5
• Unlike other scoring systems such as SOFA, APACHE II includes age and comorbidities, which are important factors in predicting outcomes 2, 6

Advantages Over Other Scoring Systems

• APACHE II outperforms SOFA in discriminative power for mortality prediction (AUC 0.81 vs. 0.75) 1, 2
• APACHE II considers age and chronic health conditions, which SOFA does not include in its assessment 2, 5

Clinical Applications and Considerations

• Regular recalculation of the APACHE II score can provide valuable information about patient progress and response to treatment 5

APACHE Score and Its Correlation with ICU Mortality

Understanding the APACHE II Score

• The APACHE II score incorporates 12 physiological measurements, age, chronic health evaluation, and admission type to provide a comprehensive assessment of disease severity 7

Correlation with ICU Mortality

• The APACHE II score demonstrates a 55.6% positive predictive value after 48 hours of ICU admission 7

Regional and Contextual Variations

• The original US APACHE II model showed variable ability to accurately predict risk of death when applied to UK patients, leading to a 'local' UK recalibration of the model 8, 9
• Different care patterns before ICU admission may explain why mortality prediction models like APACHE require adjustment in different regions or countries 8, 9, 10
• Pre-ICU care quality can significantly impact physiological measurements used in the APACHE II calculation, potentially creating a "lead time bias" 9, 10

Comparison with Other Scoring Systems

• APACHE II has demonstrated higher accuracy for predicting severe acute conditions compared to other scoring systems like Ranson, BISAP, and CTSI 7

Limitations and Considerations

• The APACHE II calculation is cumbersome and not all required parameters are routinely collected 7
• Pre-ICU care quality can significantly impact the physiological measurements used in the APACHE II calculation 8, 9, 10

APACHE II Score: Clinical Significance in ICU Patients

Clinical Applications for High Scores

• The American College of Emergency Physicians recommends an APACHE II score of 8 as the optimal cut-off, with 83.3% sensitivity and 91% specificity for mortality prediction, triggering enhanced monitoring protocols 11
• For patients with APACHE II ≥15-17, consider continuous or extended infusion of beta-lactam antibiotics rather than intermittent dosing for severe infections, which improves clinical cure rates and reduces mortality in critically ill patients 11
• Continuous beta-lactam administration shows reduced mortality (RR 0.73 [0.57-0.94]) compared to intermittent dosing for patients with APACHE II ≥20, particularly beneficial for anti-pseudomonal beta-lactam therapy 11
• Prolonged infusions of piperacillin/tazobactam are associated with significantly lower mortality (12.9% vs. 40.5%, p=0.01) compared to intermittent infusions for patients with APACHE II ≥29.5 11
• Regular recalculation of APACHE II score provides critical information, with daily scoring tracking disease progression or recovery, and pattern changes indicating response to treatment or onset of complications like sepsis, particularly valuable in severe acute pancreatitis management 12

APACHE Score: Clinical Interpretation and Risk Stratification

Predictive Performance and Clinical Applications

• The American College of Critical Care Medicine recommends using APACHE II for risk stratification in complicated intra-abdominal infections when calculated within 24 hours of hospitalization or ICU admission 13
• The Society of Critical Care Medicine suggests that APACHE II score is incorporated into validated delirium prediction models, such as the PRE-DELIRIC model, which uses APACHE II as one of 10 predictors with an AUROC of 0.77 14
• Higher APACHE scores correlate with increased delirium risk in ICU patients, according to the Society of Critical Care Medicine 14

Guideline-Endorsed Use of APACHE II for Complicated Intra‑Abdominal Infections

Risk Stratification Recommendation

• The Infectious Diseases Society of America (IDSA) recommends calculating the APACHE II score within the first 24 hours of hospitalization or ICU admission to stratify severity in adult patients with complicated intra‑abdominal infections; the score is used to guide prognosis and therapeutic decisions. 15